Asenapine: Efficacy and safety of 5 and 10 mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar i disorder

Journal of Affective Disorders

Volumn 190, Issue , 2016, Pages 103-110

  Landbloom, Ronald L ^a   Mackle, Mary ^a   Wu, Xiao ^b   Kelly, Linda ^a   Snow Adami, Linda ^a   McIntyre, Roger S ^c   Mathews, Maju ^b   Hundt, Carla ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Actavis   (United States)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Asenapine; Bipolar disorder; Mania; Mixed

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASENAPINE; ASPARTATE AMINOTRANSFERASE; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; BILIRUBIN; PLACEBO; ZOLPIDEM; FUSED HETEROCYCLIC RINGS; NEUROLEPTIC AGENT;

ADULT; AKATHISIA; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BIPOLAR I DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DSM-IV-TR; DYSGEUSIA; FEMALE; FOLLOW UP; HUMAN; HYPERSOMNIA; HYPESTHESIA; INCREASED APPETITE; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MANIA; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; MIXED MANIA AND DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAUSEA; PHASE 3 CLINICAL TRIAL; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; SIDE EFFECT; SOMNOLENCE; TREATMENT DURATION; TREATMENT OUTCOME; YOUNG MANIA RATING SCALE; ADOLESCENT; AGED; BIPOLAR DISORDER; CLINICAL TRIAL; DOSE RESPONSE; MIDDLE AGED; MULTICENTER STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84945252861     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2015.06.059     Document Type: Article

References (25)

1. American Psychiatric Association DSM-IV-TR. Diagnostic and Statistical Manual of Mental Disorders 2000 American Psychiatric Publications Arlington, VA
2. P. Amorim, Y. Lecrubier, E. Weiller, T. Hergueta, and D. Sheehan DSM-IH-R psychotic disorders: procedural validity of the mini International neuropsychiatric interview (MINI). Concordance and causes for discordance with the CIDI Eur. Psychiatry 13 1998 26 34
3. T. Barnes Adverse effect measures A.J. Rush, Handbook of Psychiatric Measures 2000 A.P. Association Washington, DC 165 166
4. T.R. Barnes A rating scale for drug-induced akathisia Br. J. Psychiatry 154 1989 672 676
5. F. Bretz, W. Maurer, W. Brannath, and M. Posch A graphical approach to sequentially rejective multiple test procedures Stat. Med. 28 2009 586 604
6. W. Guy Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology, Revised 1976 United States Department of Health, and Welfare Washington, DC 217 222
7. W. Guy Abnormal Involuntary Movement Scale (AIMS). ECDEU Assessment Manual for Psychopharmacology, Revised 1976 United States Department of Health, and Welfare Washington, DC 534 537
8. Y. Hochberg A sharper Bonferroni procedure for multiple tests of significance Biometrika 75 1988 800 802
9. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Introductory Guide for Standardised MedDRA Queries (SMQs), Version 16.0, MSSO-DI-6226-16.0. Available from: (http://www.meddra.org/sites/default/files/guidance/file/smq-intguide-16-0-english.pdf) (retrieved 30.09.14).
10. S.R. Kay, A. Fiszbein, and L.A. Opler The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr. Bull. 13 1987 261 276
11. R.C. Kessler, W.T. Chiu, O. Demler, K.R. Merikangas, and E.E. Walters Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Arch. Gen. Psychiatry 62 2005 617 627
12. R.S. McIntyre, M. Cohen, J. Zhao, L. Alphs, T.A. Macek, and J. Panagides A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states Bipolar. Disord. 11 2009 673 686
13. R.S. McIntyre, M. Cohen, J. Zhao, L. Alphs, T.A. Macek, and J. Panagides Asenapine versus olanzapine in acute mania: a double-blind extension study Bipolar Disord. 11 2009 815 826
14. R.S. McIntyre, M. Cohen, J. Zhao, L. Alphs, T.A. Macek, and J. Panagides Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial J. Affect. Disord. 122 2010 27 38
15. R.S. McIntyre, M. Cohen, J. Zhao, T.A. Macek, and J. Panagides Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study J. Affect. Disord. 126 2010 358 365
16. R.S. McIntyre, M. Tohen, M. Berk, J. Zhao, and E. Weiller DSM-5 mixed specifier for manic episodes: evaluating the effect of depressive features on severity and treatment outcomes using asenapine clinical trial data J. Affect. Disord. 150 2013 378 383
17. O. Mietinnen, and M. Nurminen Comparative analysis of two rates Stat. Med. 4 1985 213 226
18. S.M. Montgomery Depressive symptoms in acute schizophrenia Prog. Neuropsychopharmacol. 3 1979 429 433
19. K. Posner, G.K. Brown, B. Stanley, D.A. Brent, K.V. Yershova, M.A. Oquendo, G.W. Currier, G.A. Melvin, L. Greenhill, S. Shen, and J.J. Mann The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults Am. J. Psychiatry 168 2011 1266 1277
20. Saphris (asenapine) package insert, 2015. Actavis Inc; Saint Louis, MO.
21. M. Shahid, G.B. Walker, S.H. Zorn, and E.H. Wong Asenapine: a novel psychopharmacologic agent with a unique human receptor signature J. Psychopharmacol. 23 2009 65 73
22. G.M. Simpson, and A.J. Rush Adverse effect measures A.J. Rush, Handbook of Psychiatric Measures 2000 A. P. Association Washington, DC 163 164
23. G.M. Simpson, and J.W. Angus A rating scale for extrapyramidal side effects Acta Psychiatr. Scand. Suppl. 212 1970 11 19
24. M.K. Spearing, R.M. Post, G.S. Leverich, D. Brandt, and W. Nolen Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP Psychiatry Res. 73 1997 159 171
25. R.C. Young, J.T. Biggs, V.E. Ziegler, and D.A. Meyer A rating scale for mania: reliability, validity and sensitivity Br. J. Psychiatry 133 1978 429 435